Kenneth A Burdick bought $498k of LFST
director at LifeStance Health Group, Inc.. 114,181 shares at an average of $4.36, traded Aug 8, 2025, filed Aug 12, 2025.
Score components
- +15RoleDirector
- +18Trade size$498k at market
- 0Relative to holdingsHoldings up 3.4%
- +8Price context47% below the 52-week high
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000950170-25-107382, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 8, 2025 | POpen-market purchase Common Stock | +45,870 | $4.36 | $200k | 3,414,771 | Aug 12, 2025 |
| Aug 8, 2025 | POpen-market purchase Common Stock | +1,800 | $4.31 | $7,758 | 3,416,571 | Aug 12, 2025 |
| Aug 11, 2025 | POpen-market purchase Common Stock | +1,340 | $4.35 | $5,829 | 3,417,991 | Aug 12, 2025 |
| Aug 11, 2025 | POpen-market purchase Common Stock | +18,660 | $4.54 | $85k | 3,436,571 | Aug 12, 2025 |
| Aug 8, 2025 | POpen-market purchase Common Stockindirect: By Burdick Family LLC | +46,511 | $4.30 | $200k | 46,511 | Aug 12, 2025 |
Related signals
Other insiders at LifeStance Health Group, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 50Moderate | LifeStance Health Group, Inc. | Tpg Gp A, LLC owner | $226M 18,409,705 shares | -19% | |
| 47Moderate | LifeStance Health Group, Inc. | Vukasin Paunovich Chief Technology Officer | $541k 42,067 shares | -17% | |
| 60Notable | LifeStance Health Group, Inc. | Darren M. Black director, owner | $43M 8,407,643 shares | -20% | |
| 53Moderate | LifeStance Health Group, Inc. | Silversmith Partners I GP, LLC other | $18M 3,592,357 shares | -20% | |
| 57Moderate | LifeStance Health Group, Inc. | Summit Partners L P owner | $43M 8,407,643 shares | -20% | |
| 22Weak | LFSTsell LifeStance Health Group, Inc. | Ujjwal Ramtekkar Chief Medical Officer | $49k 9,519 shares | -8% | |
| 30Weak | LFSTsell LifeStance Health Group, Inc. | Ujjwal Ramtekkar Chief Medical Officer | $95k 16,000 shares | -12% | |
| 1Weak | LifeStance Health Group, Inc. | Robert Bessler director | $34k 4,914 shares | -0% | |
| 22Weak | LifeStance Health Group, Inc. | Robert Bessler director | $566k 75,000 shares | -5% | |
| 32Weak | LifeStance Health Group, Inc. | Lisa K Miller See Remarks | $79k 10,540 shares | -4% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.